These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36127558)

  • 1. Randomization for the susceptibility effect of an infectious disease intervention.
    Eck DJ; Morozova O; Crawford FW
    J Math Biol; 2022 Sep; 85(4):37. PubMed ID: 36127558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household.
    Datta S; Halloran ME; Longini IM
    Biometrics; 1999 Sep; 55(3):792-8. PubMed ID: 11315008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal inference in infectious diseases.
    Halloran ME; Struchiner CJ
    Epidemiology; 1995 Mar; 6(2):142-51. PubMed ID: 7742400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of causal intervention effects under contagion.
    Cai X; Loh WW; Crawford FW
    J Causal Inference; 2021 Jan; 9(1):9-38. PubMed ID: 34676152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects.
    Vanderweele TJ; Tchetgen Tchetgen EJ; Halloran ME
    Epidemiology; 2012 Sep; 23(5):751-61. PubMed ID: 22828661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk ratios for contagious outcomes.
    Morozova O; Cohen T; Crawford FW
    J R Soc Interface; 2018 Jan; 15(138):. PubMed ID: 29343627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing contamination risk in cluster-randomized infectious disease-intervention trials.
    McCann RS; van den Berg H; Takken W; Chetwynd AG; Giorgi E; Terlouw DJ; Diggle PJ
    Int J Epidemiol; 2018 Dec; 47(6):2015-2024. PubMed ID: 30376050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health Management.
    Langwig KE; Wargo AR; Jones DR; Viss JR; Rutan BJ; Egan NA; Sá-Guimarães P; Kim MS; Kurath G; Gomes MGM; Lipsitch M
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.
    Kahn R; Hitchings M; Bellan S; Lipsitch M
    Clin Trials; 2018 Apr; 15(2):207-211. PubMed ID: 29374974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
    Longini IM; Yang Y; Fleming TR; Muñoz-Fontela C; Wang R; Ellenberg SS; Qian G; Halloran ME; Nason M; Gruttola V; Mulangu S; Huang Y; Donnelly CA; Henao Restrepo AM
    Clin Trials; 2022 Dec; 19(6):647-654. PubMed ID: 35866633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining vitamin A and vaccines: convenience or conflict?
    Benn CS
    Dan Med J; 2012 Jan; 59(1):B4378. PubMed ID: 22239846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.